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Objectives: To investigate the effect of leptin on cartilage destruction. 
Methods: Collagen release was assessed in bovine cartilage explant cultures, while 
collagenolytic and gelatinolytic activities in culture supernatants were determined by 
bioassay and gelatin zymography, respectively. The expression of matrix 
metalloproteinases (MMPs) was analysed by real-time RT-PCR. Signalling pathway 
activation was studied by immunoblotting. Leptin levels in cultured osteoarthritic 
joint infrapatellar fat pad or peri-enthesal deposit supernatants were measured by 
an immunoassay. 
Results: Leptin, either alone or in synergy with IL-1, significantly induced collagen 
release from bovine cartilage by upregulation of collagenolytic and gelatinolytic 
activity. In chondrocytes, leptin induced MMP1 and MMP13 expression with a 
concomitant activation of STATs -1, -3, -5, MAPKs (JNK, Erk, p38), Akt and NF-κB 
signalling pathways. Selective inhibitor blockade of PI3K, p38, Erk and Akt pathways 
significantly reduced MMP1 and MMP13 expression in chondrocytes, and reduced 
cartilage-collagen release induced by leptin or leptin+IL-1. Interestingly, JNK 
inhibition had no effect on leptin-induced MMP13 expression or Ieptin+IL-1-induced 
cartilage-collagen release. Conditioned media from cultured white adipose tissue 
(WAT) from OA knee joint fat pads, contained leptin, induced cartilage-collagen 
release and increased MMP1 and MMP13 expression in chondrocytes; the latter 
being partially blocked with an anti-leptin antibody. 
Conclusions: This study demonstrates that leptin acts as a pro-inflammatory 
adipokine with a catabolic role on cartilage metabolism via the up-regulation of 
proteolytic enzymes and acts synergistically with other pro-inflammatory stimuli. 
Our data suggest that the infrapatellar fat pad, and other WAT, in arthritic joints is a 
local producer of leptin which may contribute to the inflammatory and degenerative 
processes in cartilage catabolism, providing a mechanistic link between obesity and 
OA. 
 
Keywords 
Leptin, osteoarthritis, cartilage, metalloproteinase 
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INTRODUCTION  
Osteoarthritis (OA) is a complex disease with genetic, mechanical
 
and environmental 
components leading to a number of changes within the joint but typified by the 
irreversible destruction of articular cartilage.(1)  Articular cartilage is composed 
predominantly of an extracellular matrix (ECM) containing proteoglycan (aggrecan) 
and collagen (mainly type II collagen). Within this ECM chondrocytes control the 
turnover and remodelling of the cartilage matrix, through regulation of the 
expression of matrix components and matrix-degrading enzymes.(2) Type II collagen 
is cleaved by matrix metalloproteinases (MMPs), including MMP-1, -8, -13 and -14 
whilst aggrecan is cleaved by ‘A disintegrin and metalloproteinase with 
thrombospondin motifs’ (ADAMTS) enzymes, most probably ADAMTS-5.(3) Together, 
these proteases release specific type II collagen or aggrecan fragments that can be 
measured in vitro and in vivo.(4) Whilst loss of aggrecan from cartilage is reversible, 
collagen breakdown is not and therefore represents an irreversible step in cartilage 
degradation.(5, 6) 
A variety of cytokines and growth factors, such as the pro-inflammatory cytokines 
tumour necrosis factor α (TNFα) and interleukin-1 (IL-1) can induce the expression of 
many of the metalloproteinases described. Further, when in combination with 
oncostatin-M (OSM), an IL-6-family cytokine, these pro-inflammatory cytokines can 
synergistically enhance the production of catabolic MMPs.(7-9) These cytokines are 
key mediators of inflammation in rheumatoid arthritis but are increasingly being 
recognised as important in OA pathogenesis.(10)  
One of the most significant risk factors for OA development is obesity (11, 12). The 
effects of obesity on OA can only partly be explained by an increase in biomechanical 
loading, since body mass index (BMI), or more specifically adiposity, is also a risk 
factor for OA in non-weight bearing joints, such as hands.(11, 13) These data suggest 
that an adipose-derived inflammatory factor acts as an obesity-related risk factor for 
OA. Adipose tissue secretes numerous cytokines and growth factors as well as the 
adipose-derived hormones, the adipokines (including adiponectin, resistin, visfatin 
and leptin)(14) to which chondrocytes are known to respond and in some cases 
produce. For example, adiponectin induces IL-8 expression by chondrocytes(15), OA 
chondrocytes are also responsive to both visfatin, which stimulates the expression of 
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 4 
ADAMTS4, ADAMTS5, MMP3 and MMP13 and induces prostaglandin E2 release, and 
resistin, that induces MMP1, MMP13, and ADAMTS4, both of which can thus be 
considered catabolic.(16, 17)  
The best characterised role of leptin is to act as a signal for the central nervous 
system to inhibit food intake and to stimulate energy expenditure(18), however it 
also has a role in various physiological processes such as lipid metabolism, 
haematopoiesis, immune function, angiogenesis, reproduction, bone formation and 
inflammation.(19-25) It is mainly secreted by adipocytes and the levels of leptin 
within the circulation correlate with the amount of white adipose tissue (WAT).(18)  
Articular cartilage produces leptin(26, 27) and expresses the functional leptin 
receptor Ob-R;(28) the expression of these two proteins is further increased in 
advanced OA and correlates with the BMI of OA patients.(29) Leptin has also been 
shown to have a pro-inflammatory effect on chondrocytes by inducing nitric oxide 
synthase.(30, 31) 
The aim of the present study was to investigate the effects of leptin alone or in 
combination with pro-inflammatory cytokines on cartilage metabolism by measuring 
its effects on the release of cartilage collagen, expression and production of 
collagenases and gelatinases, and by evaluating the mechanisms involved in these 
effects. Importantly, we show that infrapatellar fat pad, and other WAT, produce 
significant amounts of leptin, which can contribute to the pro-inflammatory milieu of 
the joint, the induction of collagenase gene expression by chondrocytes, and 
potentially cartilage catabolism, providing a biological link between obesity and OA. 
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MATERIALS AND METHODS 
IL-1α was a generous gift from Dr. K. Ray (Glaxo-SmithKline, Stevenage, UK), and 
recombinant human OSM prepared in-house using expression vectors kindly 
provided by Prof. J. Heath (University of Birmingham, UK) and methods 
described.(32) TNFα, recombinant human leptin and adiponectin, anti-human leptin 
monoclonal antibody and human leptin ELISA kit were from R&D Systems (Abingdon, 
UK). Resistin and visfatin were from First Link (UK) Ltd (Birmingham, UK). The mouse 
lgG control was from Becton-Dickinson (UK). Primary
 
antibodies against phospho-
Erk1/2 (phospho-p44/42) (#9101), phospho-p38 (#9211), phospho-JNK1/2 (#9251), 
phospho-p65 (Ser 536; #3031) and phospho-STATs were all from Cell Signaling
 
Technology (New England Biolabs, Hitchin, UK). The phospho-Akt antibodies used 
have previously been described.(33) A rabbit anti-β Tubulin antibody (ab6046) was 
from Abcam (Cambridge, UK). Secondary immunoglobulins/HRP
 
were from 
Cytomation (Dako, Glostrup, Denmark). Chemical pathway inhibitors LY294002, 
U0126, SB203580, SP600125 and Akt inhibitors IV
 
and VIII were from Merck 
Chemicals (Nottingham, UK). Tissue culture reagents were obtained from 
Lifetechnologies (Paisley, UK). 
 
Cartilage degradation and enzyme activity assay 
Bovine nasal cartilage has been previously validated as a model relevant to human 
disease(34) and was cultured as previously described.(7)  Briefly, three discs (~2 mm
3
 
discs) of bovine nasal cartilage/well were incubated ± test reagents in serum-free 
DMEM medium for 14 days, with a medium change at day 7.  Selective pathway 
inhibitors were added 30 min prior to test reagents at the concentrations 
indicated.Day 7 and day 14 supernatants were stored at -20°C. Cartilage collagen 
degradation was measured using a hydroxyproline assay (7) and collagenase 
activities in culture supernatants were determined by the 
3
H-acetylated collagen 
diffuse fibril assay (35).  Aminophenylmercuric acetate (0.67mM) was used to 
activate pro-collagenases. Gelatin zymography was used to measure gelatinase 
activity in the culture supernatants.(36) 
 
Chondrocyte isolation and culture  
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Primary human articular chondrocytes (HACs) were derived from articular cartilage 
obtained from joint replacement patients diagnosed with OA. Normal cartilage was 
obtained from neck of femur fracture (NOF) patients (no history of OA) undergoing 
joint replacement surgery. All tissue was obtained with informed consent and Ethical 
Committee approval from the Newcastle and North Tyneside Health Authority. 
Enzymatic digestion of tissue and maintenance and culture of cells were as 
previously described.(9) When cells reached 80-90% confluence without passage 
they were serum-starved for 16 hours before pre-treatment with selective pathway 
inhibitors (for 30 min at the indicated concentrations) prior to the addition of leptin,  
cytokines or WAT conditioned media at the concentrations and duration indicated as 
previously described.(37) Bovine nasal chondrocytes were isolated and cultured as 
previously described.(7, 9) 
 
RNA extraction and real-time reverse transcription polymerase chain reaction (RT-
PCR) 
Total RNA was isolated from cultured HACs or bovine chondrocytes and reverse 
transcribed using the Ambion Cells-to-cDNA II Kit (Lifetechnologies). 
Oligonucleotides were purchased from Sigma-Genosys (Poole, UK) and were as 
previously described.(36, 38) Relative quantification of genes was performed using 
the ABI Prism 7900HT sequence detection system (Lifetechnologies). Bovine 
metalloproteinase expression profiles were determined using SYBR Green (Takara, 
Cambrex, Wokingham, UK) in accordance with the manufacturer's protocol and as 
described.(38) Throughout, the 18s rRNA gene was used as an endogenous house-
keeping control. TaqMan® Probe based assays were performed using TaqMan® Gene 
Expression mastermix (Lifetechnologies) according to the manufacturer's protocol as 
previously reported.(36)  Adipokine receptor expression in NOF and OA hip cartilage 
patient samples was determined as part of a TaqMan® low-density array screen 
using assays ADIPOR1-Hs00360422_m1, ADIPOR2-Hs00226105_m1, ADIPOQ-
Hs00605917_m1, LEPR-Hs00174497_m1 and LEP-Hs00174877_m1 (Lifetechnologies), 
again normalised to the housekeeping gene 18s rRNA. 
 
Immunoblotting 
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 7 
Cells were lysed after the indicated time-points with ice-cold buffer (50mM Tris-HCl, 
pH 7.5; 1.2M glycerol; 1mM EGTA; 1mM EDTA; 1mM Na3VO4; 10mM β-
glycerophosphate; 50mM NaF; 5mM sodium pyrophosphate; 1% (v/v) Triton X-100; 
1µM microcystin-LR; 0.1% (v/v) β-mercaptoethanol; Roche protease inhibitor 
complex (Roche, UK)), particulate matter removed by centrifugation at 13,000g, 
5min at 4°C, and lysates stored at -80°C until required. Lysates were resolved by SDS-
PAGE, transferred to PVDF membranes (Millipore, Watford, UK) and subsequently 
probed using the antibodies described.  The optimum time-points for signalling 
pathway activation were based upon our previous work with HAC. (33, 36, 37, 39) 
 
White adipose tissue (WAT)-conditioned media  
The infrapatellar fat pad or peri-enthesal deposits from human OA knee joints were 
the source of WAT.  This was separated from the rest of the joint and any fibrous 
material, such as connective tissue or blood vessels, prior to dissection into small 
pieces of approximately 50mg.  The tissue was then washed twice with phosphate 
buffered saline and once with serum-free DMEM.  After washing, the WAT was 
incubated for 24hours at 37°C in DMEM culture medium containing 5% foetal calf 
serum (FCS) and antibiotics (streptomycin (100μg/ml) and penicillin (100IU/ml)), 
which was replaced with serum-free DMEM (1ml/0.3g WAT) and incubated for 
72hours at 37°C.  After harvesting, the media were filter sterilised and stored at -
80°C prior to use.  To quantify the amount of leptin present in the WAT-conditioned 
media, the Human Leptin Quantikine ELISA Kit (R&D Systems, UK) was performed 
according to manufacturers’ instructions.  
 
Statistical analysis 
For cartilage degradation assays and collagenase bioassays one-way analysis of 
variance (ANOVA) with Bonferroni post-hoc statistical tests were performed.  
Statistical differences between sample groups in the real-time RT-PCR experiments 
were assessed using the two-tailed Student’s t-test.  SPSS 15.0 software was used for 
all statistical analyses.  Significance levels were indicated as * p<0.05, ** p<0.01, and 
*** p<0.001.   
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RESULTS  
Leptin induces collagenase gene expression and cartilage resorption 
To study the effects of leptin on cartilage catabolism, bovine cartilage was 
stimulated with leptin in the absence or presence of several pro-inflammatory 
cytokines; IL-1, TNFα or OSM. Leptin alone induced low but significant (p<0.05) 
collagen release (approximately 5%) compared to control (Fig. 1A). IL-1 or TNFα 
alone induced ~30% collagen release but when combined with leptin this 
synergistically increased to >60% (Fig. 1A). This increase in collagen release was 
accompanied by an up-regulation of total and active collagenolytic and gelatinolytic 
(MMP-2 and MMP-9) activities (Fig. 1B and 1C), demonstrating a role of leptin in the 
activation of a number of proMMPs.  OSM alone or in combination with leptin did 
not effect cartilage resorption.  
Our previous work has focussed on synergy between various inflammatory 
mediators, especially with IL-1, and the potent regulation of the collagenases.(7-9, 
33, 36, 40) We therefore assessed the synergy between leptin and IL-1.  A 
concentration-dependent increase in cartilage-collagen degradation was observed 
with leptin concentrations exceeding 10µg/ml although when in combination with 
IL-1 (0.25ng/ml) even the lowest concentration of leptin tested (1µg/ml) elicited a 
synergistic increase in cartilage collagen release (Fig. 1D).  We also investigated 
whether other adipokines (visfatin, resistin and adiponectin) could induce or 
potentiate cartilage resorption but, surprisingly only leptin showed such efficacy 
(Sup. Fig. 1A) despite previous literature demonstrating their ability to induce a 
catabolic phenotype in chondrocytes(15-17) and significant expression by 
chondrocytes of adiponectin receptors (Sup. Fig. 2). 
When added to primary HAC, leptin induced the gene expression of the major 
collagenases MMP1 and MMP13. Again, when in combination with IL-1 (0.25ng/ml) 
higher concentrations of leptin (>1 µg/ml) synergistically induced these collagenases.  
(Fig. 1E and 1F).  A similar induction of MMP1 and MMP13 by leptin and leptin + IL-1 
was also observed in isolated bovine chondrocytes (Sup. Fig 1B and C), emphasising 
the suitability of the bovine cartilage model. 
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Leptin activates STAT, MAPK and Akt signalling in primary HAC 
Stimulation of primary HAC with leptin ± IL-1 activated multiple signalling pathways.  
Leptin alone induced STAT1, -3 and -5 tyrosine phosphorylation (at positions Y701, 
Y705 and Y694, respectively) but failed to induce robust STAT serine phosphorylation 
with the exception of a modest increase in STAT3 S727 phosphorylation. This was in 
contrast to IL-1 which only induced STAT serine phosphorylation. Some synergy 
between leptin and IL-1 occurred with the phosphorylation of STAT1 and STAT3 at 
S727.  These activation events declined by 60 min post-stimulation (Fig. 2A). Leptin 
alone activated all three mitogen-activated protein kinase (MAPK) pathways, 
evidenced by phosphorylation of the stress-activated protein kinase/cJun-amino-
terminal kinase JNK (T183/Y185), Erk (T202/Y204 of Erk1) and p38 (T180/Y182). 
When combined with IL-1, an increase in phosphorylated p38 and JNK1/2 were 
detected (Fig. 2B), the latter only becoming obvious by 60 min. Leptin also led to the 
phosphorylation of Akt (at S473 and Y308) although no additional phosphorylation 
was observed when combined with IL-1 (Fig. 2C). Finally, leptin led to a modest 
phosphorylation of the NF-κB subunit p65 at 20 min but, as with the serine 
phosphorylation of STAT-1/3, this was not as pronounced as that elicited by IL-1 
alone (Fig. 2C).  
 
Different signalling pathways control leptin-induced collagenase expression and 
cartilage-collagen release 
Next, to test whether leptin regulated the expression of MMP1 and MMP13 via the 
identified signalling pathways, HAC were cultured in the presence of selective 
pathway inhibitors. All the inhibitors, with the exception of Akt VIII, significantly 
suppressed leptin-induced expression of MMP1, while only the JNK inhibitor, 
SP600125, failed to inhibit leptin-induced MMP13 (Fig. 2D and E).   
In the bovine cartilage resorption assay all the inhibitors significantly reduced the 
modest collagen release elicited by leptin (Fig. 3A). When the combination of IL-1 
and leptin was used as the stimulus, only the JNK and Akt VIII inhibitors were 
ineffective at blocking resorption (Fig. 3B). This inhibitor profile was reminiscent to 
that seen for the MMP13 gene expression experiment (compare Fig. 2E and 3B).  
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WAT-conditioned culture media induce MMPs and cartilage resorption 
In order to assess whether WAT-derived leptin WAT might have an impact on 
cartilage degradation we initially confirmed that WAT-, not control, -conditioned 
media were able to induce MMP1 and MMP13 by primary bovine chondrocytes (Sup. 
Fig. 3A). Next, WAT-conditioned culture media (using fat pads from 4 different OA 
patients) were incubated with bovine nasal cartilage ± IL-1. Alone, the WAT-
conditioned media induced modest, but significant, collagen release compared with 
control-conditioned medium (Fig. 3C) and when combined with IL-1, a further 
synergistic release of proteoglycan (not shown) and collagen was observed (Fig. 3D).  
 
Leptin in WAT-conditioned media contributes to the induction of MMP1 and 
MMP13 expression  
Next, HAC were cultured with WAT-conditioned media taken from fat pads of 14 OA 
patients. Ten WAT-media samples significantly up-regulated MMP13, while the same 
ten samples, plus N1688, also significantly up-regulated MMP1 expression.  The 
levels of induction of MMP1 and MMP13 obtained were comparable to that induced 
by leptin (25µg/ml) alone (Fig. 4A).   To determine if the induction of the 
collagenases induced by the WAT-media was in part mediated by secreted leptin we 
first quantified the amount of leptin present in the WAT-conditioned media using a 
specific leptin immunoassay (Fig. 4B).  After the removal of outliers, 12 WAT-
conditioned media contained a wide-range of leptin levels from 99 to 1777pg/ml (Fig. 
4B). Using regression analysis, the amount of leptin showed a trend towards a 
positive correlation with the MMP1 and MMP13 fold-induction by these media (R
2
 = 
0.1798 and 0.4897, respectively) which approached but importantly did not reach 
significance, suggestive of a role for leptin in combination with other WAT-produced 
pro-inflammatory factors in collagenase induction. To attempt to conclusively test if 
the leptin produced by the WAT was involved in the up-regulation of the 
collagenases induced by the conditioned media, HAC were incubated with WAT-
conditioned media ± an anti-leptin antibody.  When analysing the WAT-conditioned 
media that induced each collagenase >5 fold, the leptin blocking antibody led to a 
significant reduction in the induced collagenase levels (Fig. 4C and D).  Finally, a 
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similar experiment was repeated where HAC were again incubated with WAT-
conditioned media ± an anti-leptin or control (IgG) antibody.  As expected, the anti-
leptin but not the control antibody significantly reduced the level of induction of 
both collagenases by leptin, and moreover did so in 4/5 WAT-conditioned media 
examined (Sup. Fig. 3B and C).   
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DISCUSSION  
Several studies have linked leptin, obesity and OA.(27, 41-47) For example, serum 
leptin concentrations not only correlate with BMI but are also closely related to the 
radiographic severity, joint inflammation and disease severity of OA. Others have 
reported a marked increase in leptin protein expression in OA cartilage compared to 
normal cartilage.(26) However, the most compelling evidence that leptin plays a 
direct, rather than correlative, role in OA pathogenesis comes from studies using 
leptin-signalling deficient mice. These mice are severely obese yet exhibited the 
same (increased) level of OA incidence as that of obese wild-type mice.(48)   
In the current study, we demonstrated for the first time that leptin, but surprisingly 
not the other adipokines visfatin, resistin or adiponectin, can directly induce 
cartilage collagen degradation, alone and when combined with pro-inflammatory 
cytokines (IL-1 or TNFα). Adiponectin has previously been shown to induce the 
expression of IL-8 by chondrocytes (15) but also to have a chondroprotective role.(49)  
We found little response to this adipokine in our assays even though one of its 
receptors (ADIPOR2) was highly, and moreover, differentially expressed in diseased 
cartilage. We also found bovine cartilage to be unresponsive to both resistin and 
visfatin (sup. Fig. 1), both of which have previously been reported to induce a 
number of metalloproteinases when added to chondrocytes.(16, 17) These 
discrepancies could be due to a number of factors, including tissue examined 
(cartilage vs. cells), species, source of adipokine and culture conditions. The effects 
of leptin upon cartilage collagen release were accompanied with an up-regulation of 
collagenase and gelatinase activities in the culture medium.  A recent study has 
similarly shown an induction of the collagenases from human OA cartilage following 
leptin or leptin + IL-1 stimulation.(50)  The same group also showed that leptin alone 
or in combination with IL-1 enhanced the expression of the pro-inflammatory 
mediators iNOS and COX-2, and production of NO, PGE2, IL-6 and IL-8.(43) 
Leptin signalling through leptin receptors (Ob-R/LEPR) is mediated via the JAK/STAT 
(janus kinase/signal transducers and activators of transcription) pathway, but 
additionally the phosphatidylinositol 3-kinase (PI3K)/Akt, MAPK and NF-κB pathways, 
all of which have been reported to be important in leptin signalling by chondrocytes 
(30, 43), in accordance with the data presented here. Interestingly, our data show 
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that leptin alone is a better inducer of STAT phosphorylation at the tyrosine position 
rather than serine, the latter only becoming prominent when leptin acts 
synergistically with IL-1.  This is consistent with the role of the tyrosine kinase family 
JAKs, probably JAK2, in Ob-R (LEPR) signalling.(51) We also showed for the first time 
that the MAPK and PI3K pathways are important mediators of leptin signalling in 
chondrocytes and cartilage since chemical blockade of any of the these pathways 
prevented cartilage collagen release. Interestingly, the JNK inhibitor, SP600125, did 
not inhibit either leptin+IL-1-induced cartilage-collagen release or leptin-induced 
MMP13 by chondrocytes but did block MMP1 levels, supporting the dogma that 
MMP-13 is the major type-II collagen degrading enzyme(52) and validating the 
bovine cartilage model. 
Gradual loss of articular cartilage is a major characteristic of OA, with initial changes 
including the loss of proteoglycan. With this in mind, the in vivo injection of leptin 
into the joints of rats induces cartilage proteoglycan loss and increases the 
expression of MMP-2 and -9 in articular cartilage.(46) The destructive process in OA 
is determined by an imbalance between anabolic and catabolic mediators (and their 
regulators), in the joint, and the local distribution of these mediators in the 
cartilage.(10, 52) Leptin appears to be an important local and systemic factor 
influencing cartilage/bone homeostasis.  It is likely that locally produced, rather than 
circulatory, leptin may be more important in regulating cartilage homeostasis since 
the concentration of leptin in synovial fluid is higher than in the corresponding sera 
of OA patients (29), and these levels are associated with disease activity.(26, 53) 
Moreover, expression of leptin and LEPR have previously been detected in human 
cartilage with levels significantly increased in end-stage OA cartilage.(26, 41) The 
endogenous leptin produced by chondrocytes has also been shown to induce 
MMP13 expression.(54) However, although we could detect leptin and LEPR 
expression in cartilage, neither were differentially expressed in OA in our 
experiments and the level of leptin expression detected was deemed negligible (Sup. 
Fig. 2). Therefore, we focussed on leptin production by the infrapatellar fat pad, a 
joint tissue reported to be a site of leptin production.(41)  For the first time to our 
knowledge we have shown that WAT-conditioned media, collected from cultured 
infrapatellar fat pad and other WAT of OA knee joints, contains significant quantities 
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of leptin, the amount of which correlated with the ability of the WAT-conditioned 
media to stimulate MMP1 and MMP13 expression in chondrocytes. These WAT-
conditioned media were also able to induce collagen release from cartilage cultures. 
Furthermore, the ability of these WAT-conditioned media to stimulate MMP1 and 
MMP13 expression was partially abolished by an anti-leptin antibody. Together, 
these data suggest that leptin produced by the WAT-conditioned media was in part 
responsible for the cartilage degradation observed, but importantly that these media 
contain other pro-inflammatory cytokines, such as IL-1, whose expression by WAT-
tissue we could detect (data not shown), that synergise with leptin to induce 
collagenase expression. 
Taken together our findings suggests that the infrapatellar fat pad of arthritic joints 
can be a significant local producer of leptin and may contribute to inflammatory and 
degenerative processes in OA cartilage catabolism via the up-regulation of the 
collagenolytic metalloproteinases MMP-1 and MMP-13, thus providing a direct 
mechanistic link between obesity and OA. 
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FIGURE LEGENDS: 
 
Fig. 1. Leptin in combination with pro-inflammatory cytokines induces cartilage-
collagen release from bovine cartilage by enhancing collagenolytic and 
gelatinolytic activities. Bovine nasal cartilage was treated with leptin (25µg/ml 
unless indicated otherwise) with OSM (10ng/ml), IL-1α (0.25ng/ml) or TNFα 
(10ng/ml) in serum-free medium for 14 days. The release of collagen and enzyme 
activities were assayed as described in Material and Methods. A and D, Cumulative 
collagen release by day 14 is expressed as a percentage of the total (mean ± SD, n=4). 
Inset shows an expansion of the leptin alone data for clarity. B, Active (open bars) 
and total (solid bars) collagenolytic activity values (mean ± SD, n=4). C, Gelatin 
zymography of day 14 media. Pro and active MMP-2 and MMP-9 are indicated. *p< 
0.05; **p< 0.01; ***p<0.001 vs. each respective control. Data are representative of 3 
separate cartilage experiments.  E and F, primary human articular chondrocytes were 
stimulated with leptin as indicated ± IL-1 (0.25ng/ml) for 24 hours. The expression of 
MMP1 and MMP13 and 18s were assayed by real time RT-PCR. The levels of MMP1 
(solid bars; E) and MMP13 (grey bars; F) were expressed as fold against 18s rRNA. 
*p< 0.05; **p< 0.01 vs. control or cytokine alone. Experiments were performed as 
n=4 and are representative of 3 independent experiments.   
 
Fig. 2. Signalling pathways activated after leptin and leptin+IL-1 stimulation of 
chondrocytes and their role in collagenase expression.  Primary HAC were serum-
starved overnight and then stimulated for 20 and 60 min with either leptin (25µg/ml) 
or IL-1 (0.25ng/ml) alone or in combination. Cells were lysed, and extracts 
immunoblotted with antibodies against (A) phospho-STAT1 (Y701 or S727), phospho-
STAT3 (Y705 and S727), phospho-STAT5 (Y694) and β-tubulin as loading control; (B) 
phospho-Erk (p44/42) (T202/Y204 of Erk1), phospho-JNK (SAPK)(T183/Y185), 
phospho-p38 (T180/Y182); or (C) phospho-Akt (S473 and Y308) and phospho-p65 
(S536).  D and E. Primary human chondrocytes were stimulated with leptin (25µg/ml) 
± the inhibitors; LY (LY249002, 5µM), U0126 (5µM), SB (SB203580, 10µM), SP 
(SP600125, 10µM), Akt IV (3µM) or Akt VIII (3µM) for 20 hours. Cells were pre-
treated for 30 min with inhibitors or vehicle control prior to the addition of leptin. 
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The expression of MMP1 (D) and MMP13 (E) was assayed by real time RT-PCR and 
expressed as fold relative to the control after normalisation to 18s rRNA. *p<0.05; 
**p<0.01; ***p<0.001 vs. control. Data are representative of 3 separate experiments. 
 
Fig. 3. Effects of signalling pathway inhibitors on leptin induced cartilage-collagen 
release and WAT-conditioned media cartilage degradation. A. Bovine cartilage was 
stimulated with leptin (25µg/ml) ± inhibitors; LY (LY249002, 5µM), U0126 (5µM), SB 
(SB203580, 10µM), SP (SP600125, 10µM), Akt IV (3µM) or Akt VIII (3µM) or  (B) 
leptin+IL-1 (0.25ng/ml) ± the pathway inhibitors described above, in serum-free 
medium for 14 days. Cartilage was pre-treated for 30 min with inhibitors or vehicle 
control prior to the addition of leptin or leptin+IL-1. C and D. WAT samples were 
collected from the infrapatellar fat pad of OA patients as described and incubated in 
5% FCS/DMEM culture medium (1ml medium/0.3g WAT) at 37°C for 24 hours, then 
incubated in serum-free DMEM for 3 days. 20% (v/v) WAT-conditioned media from 
four patients were then added to bovine cartilage alone (C) or +IL-1 (0.25ng/ml) (D) 
in serum-free medium for 14 days. In all experiments on day 7, media were collected 
and replaced with identical test reagents. The release of collagen was assayed as 
described in Material and Methods. Cumulative collagen release by day 14 is 
expressed as the percentage of total (n=4). *p<0.05; **p<0.01; ***p<0.001 vs. 
control. Data are representative of 3 separate experiments.   
 
Fig. 4. Leptin in WAT-conditioned media and its effect on MMP1 and MMP13 
expression. A, Primary HAC were cultured in serum-free medium for 24 hours and 
then incubated with 20% (v/v) WAT-conditioned media in DMEM for 24 hours. The 
expression of MMP1 (black) and MMP13 (grey), normalised to 18s rRNA, were 
assayed by real time RT-PCR (n=4/WAT-conditioned medium). B, The levels of leptin 
in WAT-conditioned media collected from OA fat pad were assayed by ELISA then 
expressed relative to the fold induction of MMP1 (o) or MMP13 (■) for each WAT-
medium sample. Best fit lines are leptin vs. MMP1, broken; leptin vs. MMP13, solid. 
C and D, Primary HAC were co-incubated with an anti-leptin antibody (20µg/ml) and 
20% (v/v) WAT-conditioned media in DMEM for 24 hours, then the expression of 
MMP1 (C) and MMP13 (D) assayed by real time RT-PCR and normalised to 18s rRNA 
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levels (n=3). Only WAT-media which induced a >5 fold increase in collagenase 
expression are included. *p< 0.05; **p< 0.01 and ***p<0.001 vs. basal control or 
WAT-conditioned medium induced levels.  
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Supplementary Figure 1. A. Other adipokines ±IL-1 do not induces cartilage-collagen 
release from bovine cartilage. Bovine nasal cartilage was treated with resistin (R), 
visfatin (V) or adiponectin (Ad) (all at 25µg/ml) ± IL-1 (0.25ng/ml) in serum-free 
medium for 14 days. The release of collagen from the cartilage was assayed as 
described in Material and Methods. Data are representative of 3 separate cartilage 
experiments. B and C, Primary bovine chondrocytes  stimulated with leptin as 
indicated ± IL-1 (0.25ng/ml) for 24 hours. The expression of MMP1 and MMP13 and 
18s were assayed by real time RT-PCR. The levels of MMP1 (solid bars; B) and 
MMP13 (grey bars; C) were expressed as fold against 18s rRNA. **p< 0.01 vs. control 
or cytokine alone. Experiments were performed as n=4 and are representative of 3 
independent experiments.   
 
 
Supplementary Figure 2. Comparative gene expression between cartilages from 
fracture to neck of femur (NOF) and osteoarthritis (OA) patients. The expression of 
the genes indicated were determined by real-time RT-PCR from total RNA isolated 
from OA (open) and NOF (shaded) cartilage samples. Gene expression data are 
presented as a ratio of the gene levels to those of the housekeeping gene 18s rRNA 
using the calculation 2
-∆C
T. Lines within the boxes represent the median, the boxes 
represent the 25th and 75th percentiles, and the lines outside the boxes are the 
minimum and maximum values. Only the expression of ADIPOR2 was significantly 
differentially expressed where ***p<0.001 (Mann-Whitney U-test). 
 
Supplementary Figure 3. Effects of WAT-conditioned media on collagenase 
expression.  WAT samples were collected from the infrapatellar fat pad of OA 
patients and processed as described. After culture in serum-free DMEM for 3 days,  
harvested media were then added to cell cultures at 20% (v/v) WAT-conditioned 
media in DMEM for 24 hours. B. Primary bovine nasal chondrocytes were incubated 
with WAT-conditioned media and MMP1 and MMP13 expression measured by real-
time RT-PCR and normalised to 18s rRNA in six separate experiments (with six 
replicates/WAT sample).  The average fold-induction for each WAT sample (n=19 for 
MMP1 and n=15 for MMP13) is plotted with the lines within the boxes representing 
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the median, the boxes represent the 25th and 75th percentiles, and lines outside the 
boxes are the minimum and maximum values. B and C. Primary HAC were co-
incubated with an anti-leptin antibody (20µg/ml) or irrelevant control (IgG) and 
WAT-conditioned media for 24 hours, then the expression of MMP1 (C) and MMP13 
(D) assayed by real time RT-PCR (n=3) and normalised to 18s. *p< 0.05; **p< 0.01 
and ***p<0.001 vs. basal control or WAT-conditioned medium induced levels.  
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Fig. 1. Leptin in combination with pro-inflammatory cytokines induces cartilage-collagen release 
from bovine cartilage by enhancing collagenolytic and gelatinolytic activities. Bovine nasal cartilage 
was treated with leptin (25µg/ml unless indicated otherwise) with OSM (10ng/ml), IL-1α 
(0.25ng/ml) or TNFα (10ng/ml) in serum-free medium for 14 days. The release of collagen and 
enzyme activities were assayed as described in Material and Methods. A and D, Cumulative collagen 
release by day 14 is expressed as a percentage of the total (mean ± SD, n=4). Inset shows an 
expansion of the leptin alone data for clarity. B, Active (open bars) and total (solid bars) 
collagenolytic activity values (mean ± SD, n=4). C, Gelatin zymography of day 14 media. Pro and 
active MMP-2 and MMP-9 are indicated. *p< 0.05; **p< 0.01; ***p<0.001 vs. each respective 
control. Data are representative of 3 separate cartilage experiments.  E and F, primary human 
articular chondrocytes were stimulated with leptin as indicated ± IL-1 (0.25ng/ml) for 24 hours. The 
expression of MMP1 and MMP13 and 18s were assayed by real time RT-PCR. The levels of MMP1 
(solid bars; E) and MMP13 (grey bars; F) were expressed as fold against 18s rRNA. *p< 0.05; **p< 
0.01 vs. control or cytokine alone. Experiments were performed as n=4 and are representative of 3 
independent experiments.  
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Fig. 2. Signalling pathways activated after leptin and leptin+IL-1 stimulation of chondrocytes and 
their role in collagenase expression.  Primary HAC were serum-starved overnight and then 
stimulated for 20 and 60 min with either leptin (25µg/ml) or IL-1 (0.25ng/ml) alone or in 
combination. Cells were lysed, and extracts immunoblotted with antibodies against (A) phospho-
STAT1 (Y701 or S727), phospho-STAT3 (Y705 and S727), phospho-STAT5 (Y694) and β-tubulin as 
loading control; (B) phospho-Erk (p44/42) (T202/Y204 of Erk1), phospho-JNK (SAPK)(T183/Y185), 
phospho-p38 (T180/Y182); or (C) phospho-Akt (S473 and Y308) and phospho-p65 (S536).  D and 
E. Primary human chondrocytes were stimulated with leptin (25µg/ml) ± the inhibitors; LY 
(LY249002, 5µM), U0126 (5µM), SB (SB203580, 10µM), SP (SP600125, 10µM), Akt IV (3µM) or Akt 
VIII (3µM) for 20 hours. Cells were pre-treated for 30 min with inhibitors or vehicle control prior to 
the addition of leptin. The expression of MMP1 (D) and MMP13 (E) was assayed by real time RT-PCR 
and expressed as fold relative to the control after normalisation to 18s rRNA. *p<0.05; **p<0.01; 
***p<0.001 vs. control. Data are representative of 3 separate experiments.  
122x85mm (300 x 300 DPI)  
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Fig. 3. Effects of signalling pathway inhibitors on leptin induced cartilage-collagen release and WAT-
conditioned media cartilage degradation. A. Bovine cartilage was stimulated with leptin (25µg/ml) ± 
inhibitors; LY (LY249002, 5µM), U0126 (5µM), SB (SB203580, 10µM), SP (SP600125, 10µM), Akt IV 
(3µM) or Akt VIII (3µM) or  (B) leptin+IL-1 (0.25ng/ml) ± the pathway inhibitors described above, 
in serum-free medium for 14 days. Cartilage was pre-treated for 30 min with inhibitors or vehicle 
control prior to the addition of leptin or leptin+IL-1. C and D. WAT samples were collected from the 
infrapatellar fat pad of OA patients as described and incubated in 5% FCS/DMEM culture medium 
(1ml medium/0.3g WAT) at 37°C for 24 hours, then incubated in serum-free DMEM for 3 days. 20% 
(v/v) WAT-conditioned media from four patients were then added to bovine cartilage alone (C) or 
+IL-1 (0.25ng/ml) (D) in serum-free medium for 14 days. In all experiments on day 7, media were 
collected and replaced with identical test reagents. The release of collagen was assayed as 
described in Material and Methods. Cumulative collagen release by day 14 is expressed as the 
percentage of total (n=4). *p<0.05; **p<0.01; ***p<0.001 vs. control. Data are representative of 
3 separate experiments.    
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Fig. 4. Leptin in WAT-conditioned media and its effect on MMP1 and MMP13 expression. A, Primary 
HAC were cultured in serum-free medium for 24 hours and then incubated with 20% (v/v) WAT-
conditioned media in DMEM for 24 hours. The expression of MMP1 (black) and MMP13 (grey), 
normalised to 18s rRNA, were assayed by real time RT-PCR (n=4/WAT-conditioned medium). B, The 
levels of leptin in WAT-conditioned media collected from OA fat pad were assayed by ELISA then 
expressed relative to the fold induction of MMP1 (o) or MMP13 (■) for each WAT-medium sample. 
Best fit lines are leptin vs. MMP1, broken; leptin vs. MMP13, solid. C and D, Primary HAC were co-
incubated with an anti-leptin antibody (20µg/ml) and 20% (v/v) WAT-conditioned media in DMEM 
for 24 hours, then the expression of MMP1 (C) and MMP13 (D) assayed by real time RT-PCR and 
normalised to 18s rRNA levels (n=3). Only WAT-media which induced a >5 fold increase in 
collagenase expression are included. *p< 0.05; **p< 0.01 and ***p<0.001 vs. basal control or 
WAT-conditioned medium induced levels.  
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Figure S1. A. Other adipokines ±IL-1 do not induces cartilage-collagen release from bovine 
cartilage. Bovine nasal cartilage was treated with resistin (R), visfatin (V) or adiponectin (Ad) (all at 
25µg/ml) ± IL-1 (0.25ng/ml) in serum-free medium for 14 days. The release of collagen from the 
cartilage was assayed as described in Material and Methods. Data are representative of 3 separate 
cartilage experiments. B and C, Primary bovine chondrocytes  stimulated with leptin as indicated ± 
IL-1 (0.25ng/ml) for 24 hours. The expression of MMP1 and MMP13 and 18s were assayed by real 
time RT-PCR. The levels of MMP1 (solid bars; B) and MMP13 (grey bars; C) were expressed as fold 
against 18s rRNA. **p< 0.01 vs. control or cytokine alone. Experiments were performed as n=4 
and are representative of 3 independent experiments.  
144x115mm (300 x 300 DPI)  
 
 
Page 29 of 31
http://mc.manuscriptcentral.com/ard
Annals of the Rheumatic Diseases
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
  
 
 
Figure S2. Comparative gene expression between cartilages from fracture to neck of femur (NOF) 
and osteoarthritis (OA) patients. The expression of the genes indicated were determined by real-
time RT-PCR from total RNA isolated from OA (open) and NOF (shaded) cartilage samples. Gene 
expression data are presented as a ratio of the gene levels to those of the housekeeping gene 18s 
rRNA using the calculation 2-∆CT. Lines within the boxes represent the median, the boxes represent 
the 25th and 75th percentiles, and the lines outside the boxes are the minimum and maximum 
values. Only the expression of ADIPOR2 was significantly differentially expressed where 
***p<0.001 (Mann-Whitney U-test).  
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Figure S3. Effects of WAT-conditioned media on collagenase expression.  WAT samples were 
collected from the infrapatellar fat pad of OA patients and processed as described. After culture in 
serum-free DMEM for 3 days,  h rvested media were then added to cell cultures at 20% (v/v) WAT-
conditioned media in DMEM for 24 hours. B. Primary bovine nasal chondrocytes were incubated with 
WAT-conditioned media and MMP1 and MMP13 expression measured by real-time RT-PCR and 
normalised to 18s rRNA in six separate experiments (with six replicates/WAT sample).  The average 
fold-induction for each WAT sample (n=19 for MMP1 and n=15 for MMP13) is plotted with the lines 
within the boxes representing the median, the boxes represent the 25th and 75th percentiles, and 
lines outside the boxes are the minimum and maximum values. B and C. Primary HAC were co-
incubated with an anti-leptin antibody (20µg/ml) or irrelevant control (IgG) and WAT-conditioned 
media for 24 hours, then the expression of MMP1 (C) and MMP13 (D) assayed by real time RT-PCR 
(n=3) and normalised to 18s. *p< 0.05; **p< 0.01 and ***p<0.001 vs. basal control or WAT-
conditioned medium induced levels.  
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